Antibody to SC35 (also known as SRSF2), a serine/arginine-rich splicing factor crucial for constitutive and alternative splicing – mutations are found in some cancers.
| Institute |
|---|
| Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) |
| Cat. #: | 162425 |
|---|---|
| Research Fields: | Molecular Biology |
| Application: | ELISA, WB, IF |
| Target: | SC35 |
| Reactivity: | Human, mouse |
| Clone: | SC-4F11 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Cavaloc et al. (1999) RNA. 5(3):468-83. PMID: 10094314 |
| Product description: | Antibody to SC35 (also known as SRSF2), a serine/arginine-rich splicing factor crucial for constitutive and alternative splicing – mutations are found in some cancers. |
|---|---|
| Additional notes: | Avoid repeat freezing and thawing cycles. Does not contain any preservative. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1, k |
| Immunogen: | Synthetic peptide coupled to Ovalbumin: (C)-KSPPKSPEEEGAVSS corresponding to aa 207-221 of. human SC35. |
| Target background: | SC35 (also known as SRSF2) is a serine/arginine-rich splicing factor crucial for constitutive and alternative splicing, and its mutations are found in some cancers. |
|---|
| Storage conditions: | -20°C (up to 3 years) |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.